The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. This collaboration, between Bioquark Inc. and Ectocrine Technologies LLC, is the first of its kind to explore the possibilities for the benefit of humanity.
Bioquark, Inc., an innovative life sciences company focused biotherapeutic development for human regeneration and disease reversion, and Ectocrine Tec ...